Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP232263.RA34LeDM2S17uASvVb2HLSYlSOfGSJQThaL1_msmeKIIM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP232263.RA34LeDM2S17uASvVb2HLSYlSOfGSJQThaL1_msmeKIIM130_assertion type Assertion NP232263.RA34LeDM2S17uASvVb2HLSYlSOfGSJQThaL1_msmeKIIM130_head.
- NP232263.RA34LeDM2S17uASvVb2HLSYlSOfGSJQThaL1_msmeKIIM130_assertion description "[We show that skin tumor progression parallels enhanced AKT activation and increased resistance to cisplatin-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232263.RA34LeDM2S17uASvVb2HLSYlSOfGSJQThaL1_msmeKIIM130_provenance.
- NP232263.RA34LeDM2S17uASvVb2HLSYlSOfGSJQThaL1_msmeKIIM130_assertion evidence source_evidence_literature NP232263.RA34LeDM2S17uASvVb2HLSYlSOfGSJQThaL1_msmeKIIM130_provenance.
- NP232263.RA34LeDM2S17uASvVb2HLSYlSOfGSJQThaL1_msmeKIIM130_assertion SIO_000772 21351258 NP232263.RA34LeDM2S17uASvVb2HLSYlSOfGSJQThaL1_msmeKIIM130_provenance.
- NP232263.RA34LeDM2S17uASvVb2HLSYlSOfGSJQThaL1_msmeKIIM130_assertion wasDerivedFrom befree-20150227 NP232263.RA34LeDM2S17uASvVb2HLSYlSOfGSJQThaL1_msmeKIIM130_provenance.
- NP232263.RA34LeDM2S17uASvVb2HLSYlSOfGSJQThaL1_msmeKIIM130_assertion wasGeneratedBy ECO_0000203 NP232263.RA34LeDM2S17uASvVb2HLSYlSOfGSJQThaL1_msmeKIIM130_provenance.